ROR1: A Potential Drug Target for Inactive TPK-Transmembrane Receptors

Target Name: ROR1

NCBI ID: G4919

ROR1: A Potential Drug Target for Inactive TPK-Transmembrane Receptors

ROR1: A Potential Drug Target and Biomarker for Inactive Tyrosine-Protein Kinase Transmembrane Receptor-Mediated Diseases

Introduction

Inactive tyrosine-protein kinase (Tyrosine-Protein Kinase, TPK) transmembrane receptors are a family of G protein-coupled receptors (GPCRs) that play a crucial role in various cellular processes, including signaling, cell survival, and metabolism. These receptors are involved in the regulation of various cellular processes, including cell adhesion, migration, angiogenesis, and hormone signaling. ROR1 is a well-known TPK transmembrane receptor that has been extensively studied for its role in various cellular processes.

ROR1 Receptor Interaction with ligand

ROR1 is a transmembrane receptor that is involved in the regulation of cell adhesion, migration, and the production of angiogenesis. The ROR1 receptor is composed of an extracellular domain, a transmembrane segment, and an intracellular domain. The transmembrane segment consists of two main subdomains : the N-terminus and the C-terminus. The N-terminus is involved in the formation of the receptor complex with ligand, while the C-terminus is involved in the intracellular signaling pathway.

The ROR1 receptor is involved in the regulation of cell adhesion by interacting with various ligands, including protein kinases, phosphatidylinositol (PI) molecules, and GTPases. One of the well-studied ligand is called TRK-1, which is a GTPase that is involved in the regulation of cell adhesion and migration. TRK-1 has been shown to interact with the ROR1 receptor and regulate its activity.

In Active and Inactive Forms of ROR1

ROR1 is a versatile receptor that can exist in either an active or inactive form. The active form of ROR1 is associated with the formation of the TRK-1-ROR1 complex and is involved in the regulation of cell adhesion and migration. The inactive form of ROR1 is associated with the cytoplasmic side of the cell and is involved in the regulation of cell survival and metabolism.

The active form of ROR1 is formed by the interaction between the ROR1 transmembrane segment and various ligands, including TRK-1. This interaction between ROR1 and TRK-1 is critical for the regulation of cell adhesion and migration.

Drugs that interact with ROR1

Drugs that interact with ROR1 can modulate its activity and have therapeutic effects on various cellular processes. One of the most well-known drugs that interacts with ROR1 is gefitinib, which is a inhibitor of the PI3K/Akt signaling pathway. Gefitinib has been shown to inhibit the activity of TRK-1 and reduce the formation of the TRK-1-ROR1 complex, thereby modulating the activity of ROR1.

Another drug that interacts with ROR1 is rapamycin, which is an inhibitor of the mTOR signaling pathway. Rapamycin has been shown to inhibit the activity of S6, a protein that is involved in the regulation of ROR1 activity, and reduce the formation of the TRK- 1-ROR1 complex, thereby modulating the activity of ROR1.

Conclusion

ROR1 is a TPK transmembrane receptor that is involved in the regulation of various cellular processes, including cell adhesion, migration, and the production of angiogenesis. The ROR1 receptor is composed of a transmembrane segment that is involved in the formation of the receptor complex with various Ligands, including TRK-1. Drugs that interact with ROR1, such as gefitinib and rapamycin, have been shown to modulate its activity and have therapeutic effects on various cellular processes. Therefore, ROR1 is a potential drug target and biomarker for the treatment of diseases associated with inactive tyrosine-protein kinase.

Protein Name: Receptor Tyrosine Kinase Like Orphan Receptor 1

Functions: Has very low kinase activity in vitro and is unlikely to function as a tyrosine kinase in vivo (PubMed:25029443). Receptor for ligand WNT5A which activate downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443, PubMed:27162350). In inner ear, crucial for spiral ganglion neurons to innervate auditory hair cells (PubMed:27162350)

More Common Targets